The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.
Weight loss drugs continue to make headlines. A new study conducted by researchers from the University of Southern ...
Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Hosted on MSN1d
Zealthy vs Ro: Which Weight Loss Plan Works Best?Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...
Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...
An obesity medicine physician writes that weight-loss drugs such as Ozempic have been getting a bad rap, almost as if those ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback